The effect of ouabain on sodium- and potassium-activated adenosine triphosphatase from the hearts of several mammalian species.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000818:Animals; D001647:Bile Acids and Salts / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007700:Kinetics; D008094:Lithium / Q000494:pharmacology; D008274:Magnesium; D008297:Male; D008832:Microchemistry; D008861:Microsomes / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology*; D010042:Ouabain / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D012756:Sheep; D012964:Sodium / Q000494:pharmacology*; D013045:Species Specificity; D013552:Swine
D001647:Bile Acids and Salts; D010042:Ouabain; D011189:Potassium Chloride; D008094:Lithium; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011188:Potassium